# Summit Therapeutics Inc. (SMMT) — capital_raise/atm_program [announced]
Source: SEC API (secapi.ai) · situation sit_178b8e629d85f9cc78b7 · retrieved 2026-08-11T16:11:13.149Z

## Overview
Summit Therapeutics Inc. is a pharmaceutical company developing drug candidates for various therapeutic areas.

Summit Therapeutics Inc. entered into a distribution agreement with J.P. Morgan Securities LLC on July 23, 2026, establishing an at-the-market (ATM) offering program. Under the agreement, the Company may offer and sell shares of its common stock with an aggregate offering price of up to $380,000,000. J.P. Morgan will act as sales agent and receive a commission of up to 3.0% of the gross sales price per share sold. The Company is not obligated to sell any shares under the agreement and may suspend or terminate the offering at any time. Sales may be made at market prices or at negotiated prices through ordinary brokers' transactions on the Nasdaq Global Market or other existing trading markets.

## Terms
- Counterparty: J.P. Morgan Securities LLC · Deal value: $380.0M · Consideration: cash

## Key dates
- Announced 2026-07-23

## Timeline
- 2026-07-23 · 8-K (0001193125-26-314214): 8-K - Summit Therapeutics Inc. — *Summit Therapeutics Inc. is a pharmaceutical company developing drug candidates for various therapeutic areas.* Summit Therapeutics Inc. entered into a distribution agreement with J.P. Morgan Securities LLC on July 23, 2026, establishing an at-the-market (ATM) offering program. Under the agreement, the Company may offer and sell shares of its common stock with an aggregate offering price of up to $380,000,000. J.P. Morgan will act as sales agent and receive a commission of up to 3.0% of the gross sales price per share sold. The Company is not obligated to sell any shares under the agreement and may suspend or terminate the offering at any time. Sales may be made at market prices or at negotiated prices through ordinary brokers' transactions on the Nasdaq Global Market or other existing trading markets.
  https://www.sec.gov/Archives/edgar/data/1599298/0001193125-26-314214.txt

## Citations
- 0001193125-26-314214 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526314214